Intuitive
Maker of the da Vinci surgical robots and the Ion endoluminal system
About
Intuitive, listed on Nasdaq as ISRG, builds the da Vinci family of robotic-assisted surgical systems and the Ion endoluminal system for lung biopsy. It ended 2025 with 11,106 da Vinci systems installed worldwide and reported 2025 revenue of $10.06 billion, most of it from instruments and accessories used in each procedure.
Key stats
- Latest funding
- —
- Total funding
- —
- Latest valuation
- —
- Founded
- —
- Country
- United States
ResearchAll papers
Recent newsAll news
- BusinessIntuitive places 468 da Vinci robots as upgrades to da Vinci 5 accelerate, and raises its margin outlook for a second time
- BusinessMicroPort MedBot doubles revenue to RMB551 million as Toumai exports reach 73% of 2025 sales
- BusinessIntuitive passes $10 billion in revenue as da Vinci 5 takes half of its robot shipments, but guides procedure growth lower
- MarketEdge Medical lists in Hong Kong after retail demand of 1,092 times, betting its surgical robots on export markets
- ProductJohnson & Johnson files Ottava surgical robot with the FDA, seeking a De Novo route into general surgery